PF-02413873 NEW
| Price | $34 | $46 | $80 |
| Package | 1mg | 2mg | 5mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: PF-02413873 | CAS No.: 936345-35-6 |
| Purity: 99.90% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | PF-02413873 |
| Description | PF-02413873 is a competitive antagonist of nonsteroidal progesterone receptor with a Ki of 2.6 nM. PF-02413873 can be used in studies about the treatment of gynecological conditions such as endometriosis. |
| In vitro | PF-02413873 induces nuclear translocation only at high concentrations (>3 μM). PF-02413873 shows a derived Ki of 9.7 nM in the T47D native functional assay[3]. |
| In vivo | In cynomolgus macaques, PF-02413873 (3 mg/kg; p.o.) exhibits a t1/2 of 4.2 h, a Cmax of 162 ng/mL and CL/F of 41 mL/min/kg. PF-02413873 (2.5 and 10 mg/kg; p.o.) reduces the endometrial thickness of 43 and 56%, respectively[3]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : < 10 mg/mL (27.82 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. DMSO : 125 mg/mL (347.76 mM), Sonication and heating to 60℃ are recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (27.82 mM), Suspension. |
| Keywords | translocation | ProgesteroneReceptor | progesterone receptor | progesterone | PF-2413873 | PF2413873 | PF-02413873 | PF 2413873 | PF 02413873 | nuclear | NR3C3 | nonsteroidal | Inhibitor | inhibit | endometrial |
| Inhibitors Related | Chlormadinone acetate | Vilaprisan | Mifepristone | Lynestrenol | Medroxyprogesterone Acetate | Progesterone | Levonorgestrel | 17α-Hydroxyprogesterone | Dydrogesterone | Ulipristal acetate | Megestrol acetate | Altrenogest |
| Related Compound Libraries | Bioactive Compound Library | ReFRAME Related Library | Anti-Breast Cancer Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Orally Active Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1980.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-21 | |
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-05 | ||
| $5.00 |
VIP8Y
|
Jinan Finer Chemical Co., Ltd
|
2026-07-13 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY